Browse Articles

Blockchain databases: Encrypted for efficient and secure NoSQL key-store

Mehrota et al. | Mar 18, 2023

Blockchain databases: Encrypted for efficient and secure NoSQL key-store
Image credit: Ayushi Mehrota & David Kim

Although commonly associated with cryptocurrency, blockchains offer security that other databases could benefit from. These student authors tested a blockchain database framework, and by tracking runtime of four independent variables, they prove this framework is feasible for application.

Read More...

Changing public opinions on genetically modified organisms through access to educational resources

Klein et al. | Jul 26, 2022

Changing public opinions on genetically modified organisms through access to educational resources

Genetically modified organisms (GMOs) are crops or animals that have been genetically engineered to express a certain physical or biological characteristic and have various benefits that have made them become increasingly popular. However, the public has had mixed reactions to the use of GMOs, with some skeptical of their safety. The purpose of this study was to evaluate how opinions on genetically modified foods can change from exposure to small amounts of information

Read More...

Upregulation of the Ribosomal Pathway as a Potential Blood-Based Genetic Biomarker for Comorbid Major Depressive Disorder (MDD) and PTSD

Ravi et al. | Aug 22, 2018

Upregulation of the Ribosomal Pathway as a Potential  Blood-Based Genetic Biomarker for Comorbid Major Depressive Disorder (MDD) and PTSD

Major Depressive Disorder (MDD), and Post-Traumatic Stress Disorder (PTSD) are two of the fastest growing comorbid diseases in the world. Using publicly available datasets from the National Institute for Biotechnology Information (NCBI), Ravi and Lee conducted a differential gene expression analysis using 184 blood samples from either control individuals or individuals with comorbid MDD and PTSD. As a result, the authors identified 253 highly differentially-expressed genes, with enrichment for proteins in the gene ontology group 'Ribosomal Pathway'. These genes may be used as blood-based biomarkers for susceptibility to MDD or PTSD, and to tailor treatments within a personalized medicine regime.

Read More...